Biologic

Dupixent® (dupilumab) Authorized within the U.S. because the First Biologic Drugs for Younger Youngsters with Uncontrolled Persistent Spontaneous Urticaria (CSU)
Partnerships

Dupixent® (dupilumab) Authorized within the U.S. because the First Biologic Drugs for Younger Youngsters with Uncontrolled Persistent Spontaneous Urticaria (CSU)